Term ended Oct 22, 2024 · High confidence
20-year base term ended Oct 22, 2024
USPTO later recorded it as expired for non-payment on Jun 1, 2026.
Held by H. Lundbeck A/S
Filed Aug 30, 2012 as application 13/598,885 · Granted Apr 29, 2014
Base term, 20 years from filing
Today
Term ended Oct 22, 2024
2004
2026
Clock starts
Oct 22, 2004
Oct 22, 2004
Term ended
Oct 22, 2024
Oct 22, 2024
Granted
Apr 29, 2014
Apr 29, 2014
base term
after the term ends
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,268,582, to Oct 22, 2024. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 22, 2004, when application PCT/US2004/035302, the earliest non-provisional in its chain, was filed (this one was filed Aug 30, 2012) | Oct 22, 2024 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,268,582) | resolves to Oct 22, 2024, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | term ended | High confidence |
| USPTO status record | Recorded as expired for non-payment on Jun 1, 2026, after the term ended | no change | High confidence |
| Computed term end | The steps above, in order | Oct 22, 2024 | High confidence |
This family
| Application PCT/US2004/035302 | PCT application no patent term | no patent term |
| US 7,927,863 | In force no later than Nov 2027 | no later than Nov 2027 |
| US 8,268,582 | Term ended Jun 2026 | Jun 2026 |
| US 9,873,746 | Term ended May 2025 | May 2025 |
| US 8,709,756 | this patent Oct 2024 | Oct 2024 |
| US 10,155,819 | Term ended Oct 2024 | Oct 2024 |
| US 10,259,883 | Term ended Oct 2024 | Oct 2024 |
| US 11,447,560 | Term ended May 2025 | May 2025 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 25, 2014 Reel 32289, frame 791 | Alder Biopharmaceuticals, Inc. | Alderbio Holdings LLC | Assignment of Assignor's Interest |
| Jun 23, 2020 Reel 53020, frame 331 | Alderbio Holdings LLC | H. Lundbeck A/S | Assignment of Assignor's Interest |
| Sep 3, 2020 Reel 53681, frame 224 | Alder Biopharmaceuticals, Inc. | Lundbeck Seattle Biopharmaceuticals, Inc. | Change of Name |
| Sep 3, 2020 Reel 54161, frame 877 | Lundbeck Seattle Biopharmaceuticals, Inc. | H. Lundbeck A/S. | Assignment of Assignor's Interest |
| Jun 2, 2021 Reel 56449, frame 543 | Lundbeck Seattle Biopharmaceuticals, Inc. | H. Lundbeck A/S | Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 054161 Frame: 0877. Assignor(S) Hereby Confirms the Assignment. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,268,582, ends no earlier than this term, so it caps nothing.
Citations
2
later US patents cite this one
That is below the median of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.